Apria’s long, bumpy road leads to Indianapolis
Indianapolis’ newest publicly traded company, home-health care provider Apria Inc., is slowly moving its headquarters here, to its regional distribution center on the city’s southeast side.
Health Care & Life Sciences
Articles
Hope at Lilly after years of Alzheimer’s failures
Lilly has spent three decades and more than $3 billion trying to find a way to treat Alzheimer’s disease. Its latest drug, donanemab, finally shows real promise.
Anthem paying $594M to settle antitrust litigation, but deal terms might fuel growth
Paying a half-billion-dollar settlement might seem painful, but health care observers say resulting changes to Blue Cross Blue Shield rules are so favorable to Anthem’s growth prospects that the deal is a huge win.
Local senior-living complex more than doubles assisted-living units in $5M expansion
The expansion will consist of 32 new one-bedroom apartments and five two-bedroom residences, bringing to 67 the number of assisted-living apartments at the complex.
Startup quietly building bone marrow bank in Indianapolis
Ossium Health wants to build a huge bank of bone marrow and stem cells from deceased organ donors to treat patient with blood cancers and to improve organ transplantations.
Lilly to help Dutch biotech develop cancer therapies in deal worth up to $1.6B
Merus N.V. specializes is so-called CD3 engaging T-cell therapies, a growing area of cancer research, based on immunotherapy, or using the immune system’s T cells to find and shrink tumors
Bill would require nursing homes to allow ‘compassionate care’ visits during pandemic
The legislation, Senate Bill 202, would allow designated family members to visit residents under end-of-life and other serious circumstances.
Indiana scrambles to get COVID vaccines into arms
As hospitals and health departments scramble to erect temporary clinics, the big questions are how fast states can roll out the vaccines and how long it will take for people to get protected.
Lilly suspends contributions to 4 Indiana Congress members over certification votes
Several other Indiana companies also say they are suspending contributions to all candidates or are taking a close look at the matter.
In midst of pandemic, drugmakers raise prices on hundreds of prescription drugs
So far this month, drugmakers have hiked prices on 636 drugs, according to research by GoodRx, which tracks prescription drug prices and offer a mobile app to help consumers find the lowest prices on hundreds of drugs.
WTHR reporter, anchor McCutcheon leaves for life sciences job
Matt McCutcheon, a reporter and anchor for WTHR-TV Channel 13 since 2013, says he has “retired” from the news industry and is taking a corporate communications gig.
Lilly’s COVID treatment sparks little demand
For a highly touted drug meant to keep throngs of people out of hospitals during a pandemic, Eli Lilly and Co.’s wonder treatment bamlanivimab sure has been slow to catch on.
How you can keep a close eye on vaccinations in Indiana
The state’s new dashboard on COVID-19 vaccines provides interesting breakdowns on who is getting vaccinated, by county, by gender, by race, by age and a host of other statistics sure to please any proud data geek.
Indiana’s life sciences sector racks up annual record $257M in venture funding
The 39 companies that won venture funding represent a wide range of therapeutics, devices and health information technology.
The shrinking Pfizer vaccine allotment: An Indiana mystery wrapped in a riddle
Last week, state health officials said they expected to initially receive 55,575 doses of Pfizer’s COVID-19 vaccine, and had already begun vaccinating front-line health care workers. But just five days later, state officials and hospitals are keeping mum about how many doses they actually received, except to say it was fewer than expected.
Hospitals discharge patients early to free beds during pandemic
Hospitals are discharging patients several days earlier than they otherwise would, sending them home sometimes with oxygen machines, intravenous lines and powerful medicines.
Lilly starting new trial for COVID-19 antibody, potentially widening already red-hot market
Lilly said it will enroll up to 500,000 people in its latest study, with at least 5,000 people expected to receive bamlanivimab therapy. The drugmaker is partnering with health insurer UnitedHealth Group to see if the drug will help high-risk people.
Statewide pandemic numbers hit new heights in November
In every significant statistical category, November has been a record-setter for the COVID-19 pandemic in Indiana, with cases, deaths and hospitalizations far exceeding even the early months of the coronavirus outbreak.
Amid pandemic, Ascension St. Vincent parent shows dramatic swing from red ink to black
Despite the change in fortunes, Ascension signaled that it is not yet out of the woods, noting that “consumer confidence and healthcare hesitation as a result of COVID-19 continue to affect Ascension markets, to varying degrees.”
The check is in the mail from health insurers, but Hoosiers won’t get big payday
Under the Affordable Care Act, health insurers are required to spend 80% to 85% of the revenue they get from premiums on medical care. If they don’t, they have to issue rebates or credits to make up the difference.